The global neurostimulation market is on a trajectory of impressive expansion, with projections indicating a rise from USD 6,221.2 million in 2023 to an estimated USD 15,417.4 million by 2033. This ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

Credit: Neurovalens. Modius Sleep is an electrical vestibular nerve stimulator that sends signals to a neural pathway that connects to the hypothalamus. Modius Sleep lowered Insomnia Severity ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

The Affera mapping and ablation system with the Sphere-9 catheter [Images courtesy of Medtronic] Medtronic (NYSE:MDT) today said it received FDA approval for its Affera mapping and ablation system ...

Occipital nerve stimulation is widely considered to be the first choice neurostimulation procedure for chronic cluster headache. Hypothalamic stimulation is an invasive procedure for drug ...

24, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug Administration (FDA) approval of the Affera™ Mapping and ...

Image credit: Lightspring / Shutterstock. Nexalin Technology has partnered with the University of California, San Diego, to start a clinical trial evaluating the company’s neurostimulation device, Gen ...

Nexalin Technology has partnered with the University of California, San Diego, to start a clinical trial evaluating the company’s neurostimulation device, Gen-3 Halo headset, as an at-home ...